Figure 1From: Therapies for type 2 diabetes: lowering HbA1c and associated cardiovascular risk factorsAmerican Diabetes Association/European Association for the Study of Diabetes consensus guidelines treatment algorithm for patients with type 2 diabetes mellitus. *Sulfonylureas other than glyburide or chlorpropamide. †Insufficient clinical use to be confident regarding safety. GLP-1, glucagon like peptide-1. Reprinted with permission from Nathan et al (2009) [21].Back to article page